Parenteral and oral formulations of benzimidazoles

Details Parenteral and oral formulations of benzimidazoles Parenteral and oral formulations of benzimidazoles

2003-08-13

2008-09-02

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S339000

Reexamination Certificate

active

07419996

ABSTRACT:
Pharmaceutical compositions of a benzimidazole or a benzimidazole derivative are disclosed. For example, in certain embodiments the pharmaceutical compositions include a benzimidazole, PEG 400, and a dipolar aprotic solvent. In other embodiments, pharmaceutical compositions include a benzimidazole, an oil, a dipolar aproptic solvent, and a surfactant. In certain embodiments, the benzimidazole is mebendezole. The pharmaceutical compositions are formulated for delivery to a subject by any means, and include formulations for oral and parenteral delivery.

REFERENCES:
patent: 5124158 (1992-06-01), Ruwart et al.
patent: 5256681 (1993-10-01), Raeymaekers et al.
patent: 5645856 (1997-07-01), Lacy et al.
patent: 6114369 (2000-09-01), Tanikawa et al.
patent: 6312712 (2001-11-01), Whittle et al.
patent: 2004/0052824 (2004-03-01), Abou Chacra-Vernet et al.
patent: 1246334 (2000-03-01), None
patent: 0427582 (1991-05-01), None
patent: WO 02/067932 (2002-09-01), None
Marquez et al., Colloid Polymer Science (2007) 285:1119-1128.
Brugmans et al., “Mebendazole in enterobiasis radiochemical and pilot clinical study in 1,278 subjects,”JAMA, 217(3):313-316, 1971.
Davis and Rowley, In:Processing of bone marrow for transplantation, McCarthy et al. (Eds.), American Assoc. Blood Banks, CA, 41-62, 1990.
Friedman and Platzer, “Interaction of anthelmintic benzimidazoles and benzimida zole derivatives with bovine brain tubulin,”Biochim. Biophys. Acta, 544(3):605-614, 1978.
Friedman and Platzer, “Interaction of anthelmintic benzimidazoles with ascaris suum embryonic tubulin,”Biochim. Biophys. Acta, 630(2):271-278, 1980.
Gorin, “Collection, manipulation and freezing of haemopoietic stem cells,”Clin. Haematol., 15:19-48, 1986.
Gorin, In:Bone marrow and stem cell processing: A manual of current techniques, Areman et al., (Eds.), F.A.Davis Co., PA, 292-362, 1992.
Gottschall et al., “Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide,”Endocrinology, 127(1):272-277, 1990.
Keystone and Murdoch, “Diagnosis and treatment: drugs five years later: mebendazole,”Ann. Intern. Med., 91:582-586, 1979.
Kim, “Preclinical toxicology and pharmacology of dimethylacetamide, with clinical notes,”Drug. Metab. Rev., 19(3&4):345-368, 1988.
Kohler and Bachman, “Intestinal tubulin as possible target for the chemotherapeutic action of mebendazole in parasitic nematodes,”Mol. Biochem. Parasitol., 4(5-6):325-336, 1981.
Lacey and Watson, “Structure-activity relationships of benzimidazole carbamates as inhibitos of mammilian tubulin, in vitro,”Biochem. Pharmacol., 34(7):1073-1077, 1989.
Lacey, “The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles,”Int. J. Parasitol., 18(7):885-936, 1988.
Liang et al., “Preformulation Evaluations Of Anthelmintic Imidazole forAnti-neoplastic Indications”, AAPSPharmSci vol. 4, No. 4, Abstract T2330, 2002.
Lockard et al., “Efficacy and toxicity of the solvent polyethylene glycol 400 in monkey model,”Epilepsia, 2077-2084, 1979.
McGann, “Differing actions of penetrating and non penetrating cryoprotective agents,”Cryobiology, 15:382-390, 1978.
Michiels et al., “The pharmacokinetics of mebendazole and flubendazole in animals and man,”Arch. Int. Pharmacodyn Ther., 256(2):180-191, 1982.
Mukhopadhayay et al., “Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and vivo,”Clin. Cancer Res., 8(9):2963-2969, 2002.
m-AMSA. “NCI Investigational Drugs: Chemical Information,” Wachington, D.C., US Department of Health and Human Services, 134-135, 147-149, NIH Pub. 84-2141, 1984.
Russell et al., “Binding of [3H]benzimidazole carbamates to mammalian brain tubulin and the mechanism of selective toxicity of the benzimidazole anthelmintics,”Biochem Pharmacol., 43(5):1095-1100, 1992.
Sasaki et al., “The anthelmintic drug mebenzadole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells,”Mol. Cancer Ther., 1(13)1201-1209, 2002.
Spiegel and Noseworthy, “Use of nonaqueous solvents in parenteral products,”J. Pharm. Sci., 52:917-927, 1963.
Van den Bossche et al., “Mebendazole and related anthelmintics,”Chemother., 19:67-128, 1982.
Van den Bossche, “A look at the mode of action of some old and new antifilarial compounds,”Ann. Soc. Belg. Med. Trop., 61:287-296, 1981.
Watts et al., “Inhibition of acetylcholinesterase secretion from nippostrongylus brasiliensis by benzimidazole anthelmintics,”Biochem. Pharmacol., 31(19):3035-3040, 1982.
Tracy and Webster,Goodman and Gillman's the Pharmacological Basis of Therapeutics, “Drugs Used In The Chemotherapy Of Helminthiasis,” 1121-1141, 2001.
Weiss et al., “A phase I study of dimethylacetamide,”Cancer Chemother. Rep., 16:477-485, 1962.
Wilson et al., “Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy,”Am. J. Trop. Med. Hyg., 37:162-168, 1987.
Witassek et al., “Chemotherapy of alveolar echinococcosis: comparison of plasma mebendazole concentrations in animals and man,”Eur. J. Clin. Pharmacol., 20:427-433, 1981.
Yalkowsky and Roseman, In:Techniques of solubilization of drugs, Yalkowsky (Eds.), Marcel Dekker Inc., NY, 91-134, 1981.
Maurer et al., “Effects of the anthelmintics clorsulon, rafoxanide, mebendazole and arprinocid onEchinostoma caproniin ICR mice,”Journal of Helminthology, 69:373-374, 1995.

Affiliated with

Also associated with

Rating

Parenteral and oral formulations of benzimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral and oral formulations of benzimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral and oral formulations of benzimidazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3989892